KEKrystyna Ediger

Krystyna Ediger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Krystyna Ediger has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Implementation of a nurse facilitated, structured, clinical event debriefing initiative in four neonatal intensive care units

    by Krystyna Ediger, Vanessa Godbout, Faith Trinh, Shannon Bartlett, Patricia Peckham, Stuart Rose, Brenda Hiu Yan Law

    Background Neonatal intensive care units (NICUs) often experience high acuity clinical events and can benefit from clinical event debriefing. Post-event team debriefs can reinforce success, identify areas for improvement, and support healthcare providers’ (HCP) psychological coping. However, barriers exist to debriefing regularly. Objective To implement and evaluate a structured clinical event debriefing program in four NICUs within a regional neonatal program. Methods We assembled a multi-disciplinary team of clinicians and debriefing specialists, adapted an existing tool, and identified site champions. A database, debrief triggers, and feedback processes were developed. We chose charge nurses as facilitators. Facilitators were trained in 2-h virtual sessions. Debriefs were started and tracked. A post-implementation survey was conducted after 6 months. Results Eighty-one HCPs responded to the pre survey. Respondents identified time constraints and skill /availability of facilitators as barriers to clinical event debriefs. Most were comfortable with debriefs prior to implementation. Ninety-five debriefs were conducted over 6 months. Median 7 (IQR 5–8) HCPs attended. Most were led by trained nurse facilitators. Debriefs took a median 12 min (IQR 8–17), and generated recommendations for equipment, teamwork, and process issues. Barriers to implementation included availability of trained facilitators, time constraints and competing quality improvement (QI) priorities. The post-implementation survey showed positive views of structured debriefs. Participants still listed time constraints as the main barrier to debriefs, although less than prior. Conclusion Nurse-led, structured clinical event debriefing can be implemented in NICUs. Clinical event debriefs allow HCPs to participate in identifying systems issues and solutions.


  • Brain-lung-thyroid syndrome in a neonate with argininosuccinate lyase deficiency

    by Krystyna Ediger, Anne Hicks, Komudi Siriwardena, Chloe Joynt

    Argininosuccinate lyase (ASL) deficiency is a rare autosomal recessive urea cycle disorder. The severe neonatal-onset form is characterised by hyperammonaemia in the first days of life and manifests with a variety of severe symptoms. However, an index of suspicion for additional or alternative diagnoses must be maintained when the patient’s presentation is out of keeping with expected manifestations and course. We present a case of a neonate with ASL deficiency and concomitant hypotonia, severe respiratory distress, pulmonary hypertension, systemic hypotension and congenital hypothyroidism. The patient was investigated and subsequently diagnosed with brain-lung-thyroid syndrome, caused by a mutation in the NKX2-1 gene.

  • Open Access

    The curious case of the bleeding twins: Neonatal bleeding secondary to acetylsalicylic acid prescribed for preeclampsia prevention

    by Krystyna Ediger, Rozalyn Chok, Mark Belletrutti, Matthew Hicks

    Preeclampsia is a major cause of obstetric and perinatal morbidity and mortality ( 1). Guidelines recommend acetylsalicylic acid (ASA) prophylaxis in pregnant women with certain risk factors to mitigate maternal vascular dysfunction and prevent consequences of preeclampsia ( 1–3). According to Society of Obstetricians and Gynaecologists of Canada (SOGC) guidelines, low-dose ASA (75 mg/day to 162 mg/day) should be prescribed for high-risk patients. Risk factors include advanced maternal age, personal or family history of preeclampsia, pre-existing medical conditions, obesity, and multiple pregnancy. Therapy should be initiated before 16 weeks’ gestation and continued until delivery...